Pharma Co. Won't Get More Time To Keep SEC Registration
The U.S. Securities and Exchange Commission has upheld an in-house judge's decision to revoke the registration of an Illinois biopharmaceutical company's securities, saying the value of its antibiotic research does not...To view the full article, register now.
Already a subscriber? Click here to view full article